Company intelligence / Profile preview

Norwell Consumer Healthcare

Montreal, Quebec, Canadanorwellcanada.ca ↗

Ownership: Private
Development stage: Commercial

Overview

Norwell’s OTC products are clinically proven and widely available in Canada, with recent portfolio expansion through acquisition of well-known brands; no traditional drug clinical stage as all products are marketed OTC

Therapeutic areas: CardiovascularInfectious DiseasesWomen's HealthOtherGastroenterology
Modalities: Small molecule (e.g. mineral salts, acid/alkaline substances, chemical laxatives, phytomedicines)PhytomedicineDevice (nasal gels, topical products)
Industry: Biotech

Drug pipeline

1 asset

Weliva Cimidona

Commercial

Indications: Menopause

Partnerships

Boyd Pharmaceuticals (asset acquisition)Solvotrin (long-term licensing agreement)

Beyond the preview

Go deeper on Norwell Consumer Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norwell Consumer Healthcare.

Explore the full profile